Anixa Biosciences, Inc.
Price Action
Technical Summary
WEAKENINGAnixa Biosciences, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 28), showing significant lag compared to the market leaders. Earnings growth of 19% provides fundamental context to the price action. Investors should exercise caution due to high volatility (68% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $2.61 | +9.19% | ABOVE |
| 50 SMA | $2.79 | +2.24% | ABOVE |
| 100 SMA | $2.80 | +1.68% | ABOVE |
| 150 SMA | $3.09 | -7.66% | BELOW |
| 200 SMA | $3.30 | -13.53% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ANIX in an uptrend right now?
ANIX has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is ANIX overbought or oversold?
ANIX's RSI (14) is 55. The stock is in neutral territory, neither overbought nor oversold.
Is ANIX outperforming the market?
ANIX has a Relative Strength (RS) Rating of 28 out of 99. ANIX is currently lagging the broader market.
Where is ANIX in its 52-week range?
ANIX is trading at $2.85, which is 52% of its 52-week high ($5.46) and 17% above its 52-week low ($2.32).
How volatile is ANIX?
ANIX has a Beta of 1.80 and 52-week volatility of 68%. It's more volatile than the S&P 500 - expect bigger swings.